{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:56:40Z","timestamp":1776769000540,"version":"3.51.2"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-04148-w","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T13:37:36Z","timestamp":1764769056000},"page":"1708-1717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning models for predicting response to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer brain metastases: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8801-1158","authenticated-orcid":false,"given":"Bardia","family":"Hajikarimloo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Mohammadzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salem Mohammed","family":"Tos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorsa","family":"Najari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azin","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arman","family":"Hasanzade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Amin","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"4148_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082382","volume":"15","author":"V Tatineni","year":"2023","unstructured":"Tatineni V, O\u2019Shea PJ, Ozair A, Khosla AA, Saxena S, Rauf Y, et al. First-versus third-generation EGFR tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer patients with brain metastases. Cancers (Basel). 2023;15:2382. https:\/\/doi.org\/10.3390\/cancers15082382.","journal-title":"Cancers (Basel)"},{"key":"4148_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.radonc.2014.12.011","volume":"114","author":"YY Soon","year":"2015","unstructured":"Soon YY, Leong CN, Koh WY, Tham IWK. EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: a systematic review and meta-analysis. Radiother Oncol. 2015;114:167\u201372. https:\/\/doi.org\/10.1016\/j.radonc.2014.12.011.","journal-title":"Radiother Oncol"},{"key":"4148_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"key":"4148_CR4","doi-asserted-by":"publisher","first-page":"588","DOI":"10.21037\/tlcr.2016.12.06","volume":"5","author":"P Economopoulou","year":"2016","unstructured":"Economopoulou P, Mountzios G. Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy. Transl Lung Cancer Res. 2016;5:588\u201398. https:\/\/doi.org\/10.21037\/tlcr.2016.12.06.","journal-title":"Transl Lung Cancer Res"},{"key":"4148_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06448-9","volume":"23","author":"S Feng","year":"2025","unstructured":"Feng S, Liu H, Yun C, Zhu W, Pan Y. Application of EGFR-TKIs in brain tumors, a breakthrough in future? J Transl Med. 2025;23:449. https:\/\/doi.org\/10.1186\/s12967-025-06448-9.","journal-title":"J Transl Med"},{"key":"4148_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091446","volume":"13","author":"E Angeli","year":"2021","unstructured":"Angeli E, Bousquet G. Brain metastasis treatment: the place of tyrosine kinase inhibitors and how to facilitate their diffusion across the blood-brain barrier. Pharmaceutics. 2021;13:1446. https:\/\/doi.org\/10.3390\/pharmaceutics13091446.","journal-title":"Pharmaceutics"},{"key":"4148_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jmp2010001","volume":"2","author":"S Caponnetto","year":"2021","unstructured":"Caponnetto S, Cantale O, Friedlaender A, Gomes F, Daryanani S, Gelibter A, et al. A comparison between first-, second- and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small-cell lung cancer and brain metastases. J Mol Pathol. 2021;2:1\u201310. https:\/\/doi.org\/10.3390\/jmp2010001.","journal-title":"J Mol Pathol"},{"key":"4148_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11523-022-00941-7","volume":"18","author":"S Popat","year":"2023","unstructured":"Popat S, Ahn M-J, Ekman S, Leighl NB, Ramalingam SS, Reungwetwattana T, et al. Osimertinib for EGFR-mutant non-small-cell lung cancer central nervous system metastases: current evidence and future perspectives on therapeutic strategies. Target Oncol. 2023;18:9\u201324. https:\/\/doi.org\/10.1007\/s11523-022-00941-7.","journal-title":"Target Oncol"},{"key":"4148_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-025-03230-9","author":"B Hajikarimloo","year":"2025","unstructured":"Hajikarimloo B, Mohammadzadeh I, Nazari MA, Habibi MA, Taghipour P, Alaei S-A, et al. Prediction of facial nerve outcomes after surgery for vestibular schwannoma using machine learning-based models: a systematic review and meta-analysis. Neurosurg Rev. 2025. https:\/\/doi.org\/10.1007\/s10143-025-03230-9.","journal-title":"Neurosurg Rev"},{"key":"4148_CR10","doi-asserted-by":"publisher","unstructured":"Hajikarimloo B, Tos SM, Sabbagh Alvani M, Rafiei MA, Akbarzadeh D, ShahirEftekhar M, et al. Application of artificial intelligence in prediction of Ki-67 index in meningiomas: a systematic review and meta-analysis. World Neurosurg [Internet]. 2024;193:226\u201335. Available from: https:\/\/doi.org\/10.1016\/j.wneu.2024.10.089","DOI":"10.1016\/j.wneu.2024.10.089"},{"key":"4148_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10072-024-07879-w","volume":"46","author":"B Hajikarimloo","year":"2025","unstructured":"Hajikarimloo B, Habibi MA, Alvani MS, Meinagh SO, Kooshki A, Afkhami-Ardakani O, et al. Machine learning-based models for prediction of survival in medulloblastoma: a systematic review and meta-analysis. Neurol Sci. 2025;46:689. https:\/\/doi.org\/10.1007\/s10072-024-07879-w.","journal-title":"Neurol Sci"},{"key":"4148_CR12","doi-asserted-by":"crossref","unstructured":"Raissi Dehkordi N, Raissi Dehkordi N, Karimi Toudeshki K, Farjoo MH. Artificial Intelligence in diagnosis of long QT syndrome: a review of current state, challenges, and future perspectives. Mayo Clin Proc: Digital Health [Internet]. 2024;2:21\u201331. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2949761223000937","DOI":"10.1016\/j.mcpdig.2023.11.003"},{"key":"4148_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12121-z","volume":"24","author":"H Qi","year":"2024","unstructured":"Qi H, Hou Y, Zheng Z, Zheng M, Qiao Q, Wang Z, et al. Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases. BMC Cancer. 2024;24:362. https:\/\/doi.org\/10.1186\/s12885-024-12121-z.","journal-title":"BMC Cancer"},{"key":"4148_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.crad.2024.02.016","volume":"79","author":"H Qi","year":"2024","unstructured":"Qi H, Hou Y, Zheng Z, Zheng M, Sun X, Xing L. MRI radiomics predicts the efficacy of EGFR-TKI in EGFR-mutant non-small-cell lung cancer with brain metastasis. Clin Radiol. 2024;79:515. https:\/\/doi.org\/10.1016\/j.crad.2024.02.016.","journal-title":"Clin Radiol"},{"key":"4148_CR15","doi-asserted-by":"publisher","first-page":"e582","DOI":"10.1016\/j.crad.2024.01.005","volume":"79","author":"J Qu","year":"2024","unstructured":"Qu J, Zhang T, Zhang X, Zhang W, Li Y, Gong Q, et al. MRI radiomics for predicting intracranial progression in non-small-cell lung cancer patients with brain metastases treated with epidermal growth factor receptor tyrosine kinase inhibitors. Clin Radiol. 2024;79:e582. https:\/\/doi.org\/10.1016\/j.crad.2024.01.005.","journal-title":"Clin Radiol"},{"key":"4148_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101826","volume":"39","author":"T-W Wang","year":"2024","unstructured":"Wang T-W, Chao H-S, Chiu H-Y, Lu C-F, Liao C-Y, Lee Y, et al. Radiomics of metastatic brain tumor as a predictive image biomarker of progression-free survival in patients with non-small-cell lung cancer with brain metastasis receiving tyrosine kinase inhibitors. Transl Oncol. 2024;39:101826. https:\/\/doi.org\/10.1016\/j.tranon.2023.101826.","journal-title":"Transl Oncol"},{"key":"4148_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1399983","volume":"15","author":"X Tang","year":"2024","unstructured":"Tang X, Li Y, Qian W-L, Han P-L, Yan W-F, Yang Z-G. Enhancing intracranial efficacy prediction of osimertinib in non-small cell lung cancer: a novel approach through brain MRI radiomics. Front Neurol. 2024;15:1399983. https:\/\/doi.org\/10.3389\/fneur.2024.1399983.","journal-title":"Front Neurol"},{"key":"4148_CR18","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1002\/jmri.28751","volume":"58","author":"Y Fan","year":"2023","unstructured":"Fan Y, Wang X, Yang C, Chen H, Wang H, Wang X, et al. Brain-tumor interface-based MRI radiomics models to determine EGFR mutation, response to EGFR-TKI and T790M resistance mutation in non-small cell lung carcinoma brain metastasis. J Magn Reson Imaging. 2023;58:1838. https:\/\/doi.org\/10.1002\/jmri.28751.","journal-title":"J Magn Reson Imaging"},{"key":"4148_CR19","doi-asserted-by":"publisher","first-page":"7902","DOI":"10.1007\/s00330-023-09709-7","volume":"33","author":"Y Fan","year":"2023","unstructured":"Fan Y, Wang X, Dong Y, Cui E, Wang H, Sun X, et al. Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC. Eur Radiol. 2023;33:7902. https:\/\/doi.org\/10.1007\/s00330-023-09709-7.","journal-title":"Eur Radiol"},{"key":"4148_CR20","unstructured":"Batra U, Nathany S, Sharma M, Mehta A, Dhanda S, Jose JT. Machine learning-based algorithm demonstrates differences in del19 and L858R EGFR subgroups in non-small cell lung cancer: a single center experience. Am J Transl Res [Internet]. 2022;14:2677\u201384. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35559374"},{"key":"4148_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18:e1003583. https:\/\/doi.org\/10.1371\/journal.pmed.1003583.","journal-title":"PLoS Med"},{"key":"4148_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529\u201336. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009.","journal-title":"Ann Intern Med"},{"key":"4148_CR23","doi-asserted-by":"crossref","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res [Internet]. 2018;27:1785\u2013805. Available from: http:\/\/www.math.hkbu.edu.hk\/~tongt\/papers\/SMMR2018.pdf","DOI":"10.1177\/0962280216669183"},{"key":"4148_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2023.101484","volume":"25","author":"M Prasad","year":"2024","unstructured":"Prasad M. Introduction to the GRADE tool for rating certainty in evidence and recommendations. Clin Epidemiol Glob Health. 2024;25:101484. https:\/\/doi.org\/10.1016\/j.cegh.2023.101484.","journal-title":"Clin Epidemiol Glob Health"},{"key":"4148_CR25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.21037\/tlcr-20-361","volume":"10","author":"S Zhao","year":"2021","unstructured":"Zhao S, Hou D, Zheng X, Song W, Liu X, Wang S, et al. MRI radiomic signature predicts intracranial progression-free survival in patients with brain metastases of ALK-positive non-small cell lung cancer. Transl Lung Cancer Res. 2021;10:368\u201380. https:\/\/doi.org\/10.21037\/tlcr-20-361.","journal-title":"Transl Lung Cancer Res"},{"key":"4148_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2023.100521","volume":"11","author":"X Lv","year":"2023","unstructured":"Lv X, Li Y, Xu X, Zheng Z, Li F, Fang K, et al. Multisequence MRI-based radiomics nomogram for early prediction of osimertinib resistance in patients with non-small cell lung cancer brain metastases. Eur J Radiol Open. 2023;11:100521. https:\/\/doi.org\/10.1016\/j.ejro.2023.100521.","journal-title":"Eur J Radiol Open"},{"key":"4148_CR27","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1007\/s11547-022-01569-3","volume":"127","author":"Y Fan","year":"2022","unstructured":"Fan Y, Zhao Z, Wang X, Ai H, Yang C, Luo Y, et al. Radiomics for prediction of response to EGFR-TKI based on metastasis\/brain parenchyma (M\/BP)-interface. Radiol Med. 2022;127:1342\u201354. https:\/\/doi.org\/10.1007\/s11547-022-01569-3.","journal-title":"Radiol Med"},{"key":"4148_CR28","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/jmri.28441","volume":"57","author":"Y Fan","year":"2023","unstructured":"Fan Y, He L, Yang H, Wang Y, Su J, Hou S, et al. Preoperative MRI-based radiomics of brain metastasis to assess T790M resistance mutation after EGFR-TKI treatment in NSCLC. J Magn Reson Imaging. 2023;57:1778\u201387. https:\/\/doi.org\/10.1002\/jmri.28441.","journal-title":"J Magn Reson Imaging"},{"key":"4148_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.719919","volume":"11","author":"X Tang","year":"2021","unstructured":"Tang X, Li Y, Yan W-F, Qian W-L, Pang T, Gong Y-L, et al. Machine learning-based CT radiomics analysis for prognostic prediction in metastatic non-small cell lung cancer patients with EGFR-T790M mutation receiving third-generation EGFR-TKI osimertinib treatment. Front Oncol. 2021;11:719919. https:\/\/doi.org\/10.3389\/fonc.2021.719919.","journal-title":"Front Oncol"},{"key":"4148_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13448-3","volume":"7","author":"S Leger","year":"2017","unstructured":"Leger S, Zwanenburg A, Pilz K, Lohaus F, Linge A, Z\u00f6phel K, et al. A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling. Sci Rep. 2017;7:13206. https:\/\/doi.org\/10.1038\/s41598-017-13448-3.","journal-title":"Sci Rep"},{"key":"4148_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202344","volume":"13","author":"AJ Steele","year":"2018","unstructured":"Steele AJ, Denaxas SC, Shah AD, Hemingway H, Luscombe NM. Machine learning models in electronic health records can outperform conventional survival models for predicting patient mortality in coronary artery disease. PLoS ONE. 2018;13:e0202344. https:\/\/doi.org\/10.1371\/journal.pone.0202344.","journal-title":"PLoS ONE"},{"key":"4148_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/ehf2.13073","volume":"8","author":"S Shin","year":"2021","unstructured":"Shin S, Austin PC, Ross HJ, Abdel-Qadir H, Freitas C, Tomlinson G, et al. Machine learning versus conventional statistical models for predicting heart failure readmission and mortality. ESC Heart Fail. 2021;8:106\u201315. https:\/\/doi.org\/10.1002\/ehf2.13073.","journal-title":"ESC Heart Fail"},{"key":"4148_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s41512-022-00124-y","volume":"6","author":"H Smith","year":"2022","unstructured":"Smith H, Sweeting M, Morris T, Crowther MJ. A scoping methodological review of simulation studies comparing statistical and machine learning approaches to risk prediction for time-to-event data. Diagn Progn Res. 2022;6:10. https:\/\/doi.org\/10.1186\/s41512-022-00124-y.","journal-title":"Diagn Progn Res"},{"key":"4148_CR34","doi-asserted-by":"publisher","DOI":"10.2196\/23863","volume":"23","author":"J-H Wu","year":"2021","unstructured":"Wu J-H, Liu TYA, Hsu W-T, Ho JH-C, Lee C-C. Performance and limitation of machine learning algorithms for diabetic retinopathy screening: meta-analysis. J Med Internet Res. 2021;23:e23863. https:\/\/doi.org\/10.2196\/23863.","journal-title":"J Med Internet Res"},{"key":"4148_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.cjca.2021.09.004","volume":"38","author":"J Petch","year":"2022","unstructured":"Petch J, Di S, Nelson W. Opening the black box: the promise and limitations of explainable machine learning in cardiology. Can J Cardiol. 2022;38:204\u201313. https:\/\/doi.org\/10.1016\/j.cjca.2021.09.004.","journal-title":"Can J Cardiol"},{"key":"4148_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202110022","volume":"34","author":"W Ma","year":"2022","unstructured":"Ma W, Xu Y, Xiong B, Deng L, Peng R-W, Wang M, et al. Pushing the limits of functionality-multiplexing capability in metasurface design based on statistical machine learning. Adv Mater. 2022;34:e2110022. https:\/\/doi.org\/10.1002\/adma.202110022.","journal-title":"Adv Mater"},{"key":"4148_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-021-01403-2","volume":"21","author":"A Brnabic","year":"2021","unstructured":"Brnabic A, Hess LM. Systematic literature review of machine learning methods used in the analysis of real-world data for patient-provider decision making. BMC Med Inform Decis Mak. 2021;21:54. https:\/\/doi.org\/10.1186\/s12911-021-01403-2.","journal-title":"BMC Med Inform Decis Mak"},{"key":"4148_CR38","doi-asserted-by":"publisher","unstructured":"Aliferis C, Simon G. Overfitting, underfitting and general model overconfidence and under-performance pitfalls and best practices in machine learning and AI. In: Health informatics [Internet]. Cham: Springer International Publishing; 2024. pp 477\u2013524. Available from: https:\/\/doi.org\/10.1007\/978-3-031-39355-6_10","DOI":"10.1007\/978-3-031-39355-6_10"},{"key":"4148_CR39","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1044\/2023_JSLHR-23-00273","volume":"67","author":"H Ghasemzadeh","year":"2024","unstructured":"Ghasemzadeh H, Hillman RE, Mehta DD. Toward generalizable machine learning models in speech, language, and hearing sciences: estimating sample size and reducing overfitting. J Speech Lang Hear Res. 2024;67:753\u201381. https:\/\/doi.org\/10.1044\/2023_JSLHR-23-00273.","journal-title":"J Speech Lang Hear Res"},{"key":"4148_CR40","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00521-024-10437-2","volume":"37","author":"E \u015eAHiN","year":"2025","unstructured":"\u015eAHiN E, Arslan NN, \u00d6zdemir D. Unlocking the black box: an in-depth review on interpretability, explainability, and reliability in deep learning. Neural Comput Appl. 2025;37:859\u2013965. https:\/\/doi.org\/10.1007\/s00521-024-10437-2.","journal-title":"Neural Comput Appl"},{"key":"4148_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.inffus.2024.102412","volume":"108","author":"E Nasarian","year":"2024","unstructured":"Nasarian E, Alizadehsani R, Acharya UR, Tsui K-L. Designing interpretable ML system to enhance trust in healthcare: a systematic review to proposed responsible clinician-AI-collaboration framework. Inf Fusion. 2024;108:102412. https:\/\/doi.org\/10.1016\/j.inffus.2024.102412.","journal-title":"Inf Fusion"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04148-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04148-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04148-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T09:52:51Z","timestamp":1776765171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04148-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["4148"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04148-w","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study is deemed exempt from receiving ethical approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}